Clinical Trials
6 trialsNCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT05588622 2023-07-13
Meru Health Program for Cancer Patients With Depression and Anxiety
Meru Health, Inc.
Phase NA Completed
NCT01335152 2014-05-07
Online Stress Management and Coping Skills Training for Women With Breast Cancer
Talaria, Inc
Phase 1/2 Completed
NCT01402830 2013-02-11
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Janssen-Cilag, S.A.
Completed
NCT00774813 2008-10-17
Nexalin Therapy for the Treatment of Depressive Symptoms
Kalaco Scientific, Inc.
Phase 2 Completed